Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Aug 15;10(16):2406-8.
doi: 10.3748/wjg.v10.i16.2406.

E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions

Affiliations

E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions

Dong-Nan He et al. World J Gastroenterol. .

Abstract

Aim: To investigate the expressions of E-cadherin and calretinin in exfoliated cells of serous effusions and evaluate their values in distinguishing malignant effusions from benign ones.

Methods: Fresh serous effusion specimens were centrifuged and exfoliated cells were collected. Cells were then processed with a standardized procedure, including paraformaldehyde fixation, BSA-PBS solution washing and smears preparation. E-cadherin and calretinin were detected by immunocytochemistry (ICC).

Results: In the exfoliated cells of serous effusions, most of carcinoma cells only expressed E-cadherin, and most of mesothelial cells only expressed calretinin, and benign cells (lymphocytes and granulocytes) did not express either of them. For E-cadherin, 85.7% (30/35) of malignant effusions and 8.1% (3/37) of benign fluids were ICC-positive (P<0.001). The sensitivity of E-cadherin ICC in the diagnosis of malignant effusions was 85.7%, specificity 91.9%, and diagnostic rate 88.9%. For calretinin, 94.6% (35/37) of benign effusions and 11.4% (4/35) of malignant effusions were ICC-positive (P<0.001). The sensitivity of calretinin ICC in the diagnosis of benign effusions was 94.6%, specificity 88.6%, and diagnostic rate 91.7%. For diagnosis of benign and malignant effusions by combining E-cadherin ICC and calretinin ICC, the specificities were up to 100% and 97.1%, respectively.

Conclusion: E-cadherin ICC and calretinin ICC are sensitive and specific in differential diagnosis of benign and malignant serous effusion specimens and specificities are evidently improved when both markers are combined.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunocytochemistry of E-cadherin in the cells from a malignant ascites specimen. Carcinoma cells were mainly stained at cell membranes. Inflammatory cells without stain-ing were as control (Original magnification, × 400).
Figure 2
Figure 2
Immunocytochemistry of calretinin in the cells from a malignant ascites specimen. Mesothelial cells were stained strongly and some of them like “fried eggs”. Carcinoma cells and inflammatory cells without staining were as control (Original magnification, × 400).

References

    1. Chhieng DC, Yee H, Schaefer D, Cangiarella JF, Jagirdar J, Chiriboga LA, Jagirdar J, Chiriboga LA, Cohen JM. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer. 2000;90:194–200. - PubMed
    1. Ascoli V, Scalzo CC, Taccogna S, Nardi F. The diagnostic value of thrombomodulin immunolocalization in serous effusions. Arch Pathol Lab Med. 1995;119:1136–1140. - PubMed
    1. Ascoli V, Carnovale-Scalzo C, Taccogna S, Nardi F. Utility of HBME-1 immunostaining in serous effusions. Cytopathology. 1997;8:328–335. - PubMed
    1. Morgan RL, De Young BR, McGaughy VR, Niemann TH. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer. 1999;87:390–394. - PubMed
    1. Zimmerman RL, Fogt F, Goonewardene S. Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions. Anal Quant Cytol Histol. 2000;22:353–357. - PubMed